OT - buybacks - I think (perhaps it was both lt cap and Jester's) prediction that the tax cut would tend to buoy stock prices through buybacks seems to be in play. Abbvie (symbol ABBV), a pharmaceutical company, has nearly doubled in the past year, and today announced a $10 bln buyback pgm, and raised the dividend from .71 cents to .96 cents. They've had a lot of success with their drugs, but this announcement produced enough of a reaction that trading was halted for a bit. If buybacks with tax-free money supports the market prices, fine with me. The reversion to the mean valuations has to happen someday, but I have no problem with delays.